Vaxart Inc (NASDAQ:VXRT)

5.36
Delayed Data
As of Apr 16
 -0.065 / -1.20%
Today’s Change
1.84
Today|||52-Week Range
24.90
-6.13%
Year-to-Date
Should You Buy Vaxart in April?
Apr 14 / MotleyFool.com - Paid Partner Content
Is the Market For a Flu Vaccine Disappearing?
Apr 04 / MotleyFool.com - Paid Partner Content
These 2 Vaccine Stocks Are Bargains Right Now
Apr 04 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close5.43
Today’s open5.40
Day’s range5.16 - 5.40
Volume179,964
Average volume (3 months)11,765,004
Market cap$648.9M
Data as of 3:59pm ET, 04/16/2021

Growth & Valuation

Earnings growth (last year)+57.79%
Earnings growth (this year)-86.11%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-58.97%
P/E ratioNM
Price/Sales124.61
Price/Book4.92

Competitors

 Today’s
change
Today’s
% change
RIGLRigel Pharmaceutical...-0.19-5.16%
MGTXMeiraGTx Holdings PL...-0.19-1.33%
BCYCBicycle Therapeutics...-0.50-1.67%
HARPHarpoon Therapeutics...-0.18-0.89%
Data as of 3:59pm ET, 04/16/2021

Financials

Next reporting dateMay 18, 2021
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$4.0M
Annual profit (last year)-$32.2M
Net profit margin-796.34%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts